ACE Report Cover
COA2021: Effect of Oral Anticoagulant Use on Surgical Delay & Mortality in Hip Fracture Patients
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
PERI-OPERATIVE
COA2021: Effect of Oral Anticoagulant Use on Surgical Delay & Mortality in Hip Fracture Patients .

Effect of Oral Anticoagulant Use on Surgical Delay and Mortality in Hip Fracture: A Systematic Review and Meta-Analysis

COA_2021_8

Thirty-four studies involving 39,446 patients were included in this systematic review and meta-analysis comparing anticoagulated patients and non-anticoagulated patients. Outcomes of interest included the time to surgery, odds of having surgery beyond the recommended 48 hours from admission, and the odds of 30-day all cause mortality. Pooled comparisons between direct oral anticoagulants and Vitamin K antagonists were also performed. Resulted revealed that anticoagulated patients were delayed 13.7 hours to surgery compared to non-anticoagulated patients. Moreover, the odds of a >48 hour delay in operation and the odds of 30 day all cause mortality were significantly higher in the anticoagulated patient group compared to the non-anticoagulated group. No significant differences in all outcomes were observed between direct oral anti-coagulants and Vitamin K antagonists.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. COA2021: Effect of Oral Anticoagulant Use on Surgical Delay & Mortality in Hip Fracture Patients. ACE Report. 2021;45(1):4. Available from: https://myorthoevidence.com/AceReport/Show/coa2021-effect-of-oral-anticoagulant-use-on-surgical-delay-mortality-in-hip-fracture-patients

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report